tert-Butyl 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxylate

Catalog No. :
ACOKUM847
CAS No. :
1248587-70-3
Molecular Formula :
C15H21N5O2
Molecular Weight :
303.37

IUPAC Name:tert-butyl 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$6195.00Login to see priceIn stockInquiry
250mg95%$12387.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperazine-1-carboxylate
MDL No.MFCD21604142
Molecular FormulaC15H21N5O2
Molecular Weight303.37
SMILESO=C(N1CCN(C2=C3C(NC=C3)=NC=N2)CC1)OC(C)(C)C
InChI KeyKYIUIOLRCKTBSG-UHFFFAOYSA-N
Synonymtert-Butyl 4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)piperazine-1-carboxylate;4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester;1-Piperazinecarboxylic acid, 4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, 1,1-dimethylethyl ester
CAS No.1248587-70-3

Synthetic Route by SureRoute

1. ACOKUM847 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACFYWU907 route compound structure diagram
    ACFYWU9073680-69-1 In Stock
  4. Then
  5. ACOKUM847 route product structure diagram
    ACOKUM8471248587-70-3 In Stock
Inquiry

2. ACOKUM847 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEBLR561 route compound structure diagram
    ACEBLR561889939-42-8 In Stock
  2. Plus
  3. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  4. Then
  5. ACOKUM847 route product structure diagram
    ACOKUM8471248587-70-3 In Stock
Inquiry

Comments (0)